Biodesix to report first quarter 2023 financial results on may 11, 2023

Boulder, colo.--(business wire)---- $bdsx #patientsfirst--biodesix, inc. (nasdaq: bdsx), a leading data-driven diagnostic solutions company with a focus on lung disease, announced today that it will release financial results for first quarter ended march 31, 2023 after the close of trading on thursday, may 11. biodesix's management will host a conference call and webcast to discuss its financial results and provide a general business update at 4:30 p.m. eastern time on the same day. listeners can register for the webca.
BDSX Ratings Summary
BDSX Quant Ranking